These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24888779)

  • 1. δ-Catenin as a potential cancer biomarker.
    Lu Q; Lanford GW; Hong H; Chen YH
    Pathol Int; 2014 May; 64(5):243-6. PubMed ID: 24888779
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcription expression and clinical significance of dishevelled-3 mRNA and δ-catenin mRNA in pleural effusions from patients with lung cancer.
    Li XY; Liu SL; Cha N; Zhao YJ; Wang SC; Li WN; Wang EH; Wu GP
    Clin Dev Immunol; 2012; 2012():904946. PubMed ID: 22461838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of δ-catenin palmitoylation slows the progression of prostate cancer.
    Wang B; Zhou R; Wu J; Kim H; Kim K
    Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119741. PubMed ID: 38697304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-96-5p represses breast cancer proliferation and invasion through Wnt/β-catenin signaling via targeting CTNND1.
    Gao XH; Zhang YL; Zhang ZY; Guo SS; Chen XB; Guo YZ
    Sci Rep; 2020 Jan; 10(1):44. PubMed ID: 31913290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and biological role of δ-catenin in human ovarian cancer.
    Fang Y; Li Z; Wang X; Zhang S
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1769-76. PubMed ID: 22699932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of small GTPases directly correlates with expression of δ-catenin and their coexpression predicts a poor clinical outcome in nonsmall cell lung cancer.
    Zhang JY; Zhang D; Wang EH
    Mol Carcinog; 2013 May; 52(5):338-47. PubMed ID: 22213037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Review on miR-200c, A Promising Cancer Biomarker with Therapeutic Potential.
    Kumar S; Nag A; Mandal CC
    Curr Drug Targets; 2015; 16(12):1381-403. PubMed ID: 25808651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. δ-Catenin promotes tumorigenesis and metastasis of lung adenocarcinoma.
    Huang F; Chen J; Wang Z; Lan R; Fu L; Zhang L
    Oncol Rep; 2018 Feb; 39(2):809-817. PubMed ID: 29251319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm.
    Zhang JY; Wang Y; Zhang D; Yang ZQ; Dong XJ; Jiang GY; Zhang PX; Dai SD; Dong QZ; Han Y; Zhang S; Cui QZ; Wang EH
    J Pathol; 2010 Sep; 222(1):76-88. PubMed ID: 20593408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. δ-Catenin overexpression promotes angiogenic potential of CWR22Rv-1 prostate cancer cells via HIF-1α and VEGF.
    He Y; Kim H; Ryu T; Kang Y; Kim JA; Kim BH; Lee JH; Kang K; Lu Q; Kim K
    FEBS Lett; 2013 Jan; 587(2):193-9. PubMed ID: 23220088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous deficiency of delta-catenin impairs pathological angiogenesis.
    DeBusk LM; Boelte K; Min Y; Lin PC
    J Exp Med; 2010 Jan; 207(1):77-84. PubMed ID: 20048286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer.
    Lu JP; Zhang J; Kim K; Case TC; Matusik RJ; Chen YH; Wolfe M; Nopparat J; Lu Q
    Mol Cancer; 2010 Nov; 9():304. PubMed ID: 21106062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mining CK2 in cancer.
    Ortega CE; Seidner Y; Dominguez I
    PLoS One; 2014; 9(12):e115609. PubMed ID: 25541719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of p120catenin predicts poor outcome in invasive breast cancer.
    Talvinen K; Tuikkala J; Nykänen M; Nieminen A; Anttinen J; Nevalainen OS; Hurme S; Kuopio T; Kronqvist P
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1377-87. PubMed ID: 20151151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor markers: reclassification and new approaches to evaluation.
    Aziz KJ
    Adv Clin Chem; 1998; 33():169-99. PubMed ID: 10086177
    [No Abstract]   [Full Text] [Related]  

  • 16. An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin.
    Wu Y; Zhao Y; Huan L; Zhao J; Zhou Y; Xu L; Hu Z; Liu Y; Chen Z; Wang L; Huang S; He X; Liang L
    Cancer Res; 2020 Mar; 80(5):976-987. PubMed ID: 31874857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancer.
    Wang T; Chen YH; Hong H; Zeng Y; Zhang J; Lu JP; Jeansonne B; Lu Q
    Oncogene; 2009 Jan; 28(4):555-64. PubMed ID: 18978817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein 90K Promotes E-Cadherin Degradation in a Cell Density-Dependent Manner via Dissociation of E-Cadherin-p120-Catenin Complex.
    Park SY; Yoon S; Sun EG; Zhou R; Bae JA; Seo YW; Chae JI; Paik MJ; Ha HH; Kim H; Kim KK
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of extracellular delta-catenin accumulation for prostate cancer detection.
    Lu Q; Zhang J; Allison R; Gay H; Yang WX; Bhowmick NA; Frelix G; Shappell S; Chen YH
    Prostate; 2009 Mar; 69(4):411-8. PubMed ID: 19116988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia induced δ-Catenin to enhance mice hepatocellular carcinoma progression via Wnt signaling.
    Huang F; Chen J; Lan R; Wang Z; Chen R; Lin J; Fu L
    Exp Cell Res; 2019 Jan; 374(1):94-103. PubMed ID: 30458179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.